Discover how we work
We open doors
to connect
the dots.

Seeking new paths of innovation

Our mission is to explore cutting-edge science and technology opportunities with relevance for dermatology. We are an experienced team with a passion for research – and we love to discuss science. We partner with public and private institutions to establish close collaborations with a focus on what could be possible. Our ambition is to be the catalyst that transforms your work into solutions that will improve the quality of life of patients with skin disease.
Engage with us
Our goal is to accelerate the development of opportunities (assets or technologies) in collaboration with partners that have unique innovative skills by using flexible funding models in order to maximize business potential.Research Areas

Maximizing value.

Our goal is to accelerate the development of opportunities (assets or technologies) in collaboration with partners that have unique innovative skills by using flexible funding models in order to maximize business potential.
Engage with us

News from the hub

21 Jun — 2017 Novopyxis – The first start-up identified by LEO Science & Tech Hub

LEO Pharma announces an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical treatments in the skin.

The hand-held aerosol device will be clinically tested on people with alopecia, where there is a high need for alternative treatment options to painful steroid injections. Alopecia is an autoimmune disease leading to hair loss from all or some parts of the body, usually the scalp.

Read more on LINK.

 

Read moreClose
15 Jun — 2017 LEO Science & Tech Hub Announce New Collaboration to Develop Technology for Minimally-Invasive Dermal Biomarker Assessment

Cambridge, Mass., June 15, 2017 – LEO Science & Tech Hub today announced a two-year collaboration with the Karp Lab at Brigham and Women’s Hospital (BWH) to develop minimally-invasive technology to advance dermal biomarker assessment. The Karp Lab, led by Jeffrey Karp, PhD, at BWH focuses on the development of platform technology and translational research to improve patient care. LEO Science & Tech Hub is an R&D innovation unit of LEO Pharma dedicated to identifying, developing, and funding innovative solutions that improve the lives of people with skin diseases.
LEO Science & Tech Hub and the Karp Lab will explore and develop technologies that could enable frequent and minimally-invasive assessment of relevant dermal biomarkers during clinical studies as well as the potential for diagnostic use in point-of-care testing. This kind of assessment could limit the number of painful skin biopsies patients must endure, and provide physicians with immediate feedback on how well a drug regimen is working. Read more on the following link.

Read moreClose
29 Sep — 2016 Official inauguration by Her Royal Highness, Crown Princess Mary of Denmark

We are looking forward to host the official inauguration of the LEO Science & Tech Hub in Boston by Her Royal Highness, Crown Princess Mary of Denmark at the Cambridge Innovation Center (CIC) on Friday, September 30th, 2016. The event, which also includes participation from the Danish Minister for Business and Growth Troels Lund Poulsen, brings together members of the Boston life science community to explore opportunities for partnership and innovation.

(Agenda)

Read moreClose
27 Jun — 2016 Opening of US office & launch of website

After several months of preparation, we’re proud to announce the opening of our office at the Cambridge Innovation Center (CIC) and the launch of our website. We’re currently in the process of relocating from Denmark to the US and expect to be fully operational by July 13, 2016. If you’d like to hear more about our mission or discuss potential ways to collaborate, don’t hesitate to get in touch with us!

Team_wide

The team: Michael Sierra (Vice President), Georg Duenstl (Chief Scientist Pharmacology), Janni Hoejlund (Administrator, located in Denmark), Troels Marstrand (Chief Data Scientist).

Read moreClose
Contact
Michael Sierra Vice President Email me

We want to engage with partners that have unique innovative skills to generate solutions that will improve the quality of life of patients with skin disease.

Tel. +1 201 396 1645
michael.sierra@leo-scitech.com
LinkedIn